C

Cue Biopharma
D

CUE

28.140
USD
-2.36
(-7.74%)
Post Trading·28.000USD-0.140(-0.50%)
حجم التداول
8,116
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
204,420,610
المقالات
المزيد

العنوان: Cue Biopharma Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate forautoimmune diseases.